GlassScriptPhysician profile
Nephi Jones
NPI 1063906394
$1,897.95
in general payments reported to CMS, 2019-2025
11 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,233 · 2020: $95.64 · 2021: $43.43 · 2022: $161 · 2023: $105 · 2024: $140 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wardlow Enterprises | $1,097.00 | 2019 | |
| Ossio INC | $160.60 | 2021-2022 | |
| Stryker Corporation | $157.30 | 2019-2025 | N/A |
| Acera Surgical, INC. | $144.17 | 2019-2022 | |
| Vilex LLC | $105.53 | 2024 | |
| Flower Orthopedics Coporation | $91.77 | 2023 | |
| Paragon 28, INC. | $35.28 | 2025 | Ankle Fracture |
| Organogenesis INC. | $34.82 | 2024-2025 | Apligraf |
| Smith+Nephew, INC. | $28.48 | 2023-2024 | Stravix |
| Polynovo North America LLC | $22.24 | 2025 | Novosorb Btm |
| Depuy Synthes Sales INC. | $20.76 | 2025 | Va-Lcp |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nephi Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.